Saudi Fund for Development Signs 0 Million Loan Agreement to Support the Water Sector Argentina

Riyadh, Saudi Arabia — The Saudi Fund for Development (SFD) Chief Executive Officer, H.E. Sultan Al-Marshad, signed today,  a new development loan agreement marking the Fund’s first presence in the country, worth USD $100 million with the Province Governor of Córdoba, H.E. Juan Schiaretti and the Province Governor of SantaContinue Reading

“رف للنشر” توقع اتفاقية ترخيص مع ديزني  للارتقاء بالمنتجات الأدبية الموجّهة للأطفال باللغة العربية

Riyadh, Saudi Arabia, 06 October 2023: In an exciting license agreement with Disney, Raff Publishing is set to release 92 Disney stories to the MENA region, including countries such as Saudi Arabia, Egypt, Qatar, Bahrain, Jordan, Kuwait, Lebanon, Oman, and the United Arab Emirates. This marks a significant milestone asContinue Reading

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license agreement with CanariaBio, a Korean biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer. Under the terms of the agreement, Hikma has an exclusive license to commercialise Oregovomab in 18Continue Reading

Saudi Fund for Development Signs New  Million Development Loan Agreement

to Construct and Equip Schools in Tajikistan Dushanbe, Tajikistan — The Saudi Fund for Development (SFD) Chief Executive Officer, H.E. Sultan Al-Marshad, signed today a new development loan agreement with the Minister of Finance of the Republic of Tajikistan, H.E. Kahhorzoda Fayziddin Sattor, through which SFD is contributing $20 million USDContinue Reading

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license agreement with Cassiopea S.p.A., a subsidiary of Cosmo Pharmaceuticals N.V. (Cosmo). Cosmo is focused on developing and commercialising products to treat selected gastrointestinal diseases and dermatological conditions. Under the terms of the agreement, Hikma hasContinue Reading

Farnek Signs Partnership Agreement with Neutral Fuels to Reduce Carbon Emissions of its Transport Fleet

Dubai, United Arab Emirates Leading UAE-based smart and green facilities management (FM) company Farnek, has signed a partnership agreement with Dubai headquartered Neutral Fuels to reduce the amount of carbon emissions generated by its transport fleet. Farnek has made a commitment to transition to Neutral Fuels’ B7 blend biodiesel which savesContinue Reading

Hoffmann Green Signs Its First Licensing Agreement in Saudi Arabia With the Shurfah Group

CHAILLÉ-SOUS-LES-ORMEAUX, France — Hoffmann Green Cement Technologies (ISIN: FR0013451044, Mnemo: ALHGR) (Paris:ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector that designs and markets innovative clinker-free cements, announces the signature with the Shurfah Group of a 22-year exclusive licensing agreement inContinue Reading

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive licensing and commercialisation agreement with Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercialising precision, cell targeting therapies based on its proprietary Alluminox™ platform. Under the terms of the agreement, Hikma hasContinue Reading